Editor-in-Chief
Hatice Kübra Elçioğlu
Vice Editors
Levent Kabasakal
Esra Tatar
Online ISSN
2630-6344
Publisher
Marmara University
Frequency
Bimonthly (Six issues / year)
Abbreviation
J.Res.Pharm.
Former Name
Marmara Pharmaceutical Journal
Journal of Research in Pharmacy
2023 , Vol 27 , Issue 2
Myricetin can control metastasis and invasion by suppressing ATF2-related signaling pathway in Rapamycin-resistant HepG2 hepatocellular cancer cells
1Department of Medical Biochemistry, Faculty of Medicine, Aydın Adnan Menderes University, Aydın, Turkey
DOI :
10.29228/jrp.337
Hepatocellular carcinoma continues to be one of the major health problems. One of the most important
challenges in the treatment of hepatocellular cancer is gaining resistance to chemotherapy. Therefore, there is an urgent
need for discoveries of naturally occurring antitumor compounds in the diet and to elucidate the anticancer mechanisms
of action of existing dietary origin compounds. Myricetin is a dietary flavonoid and its antitumor activity is reported.
In this study, HepG2 cells were incubated with 100 nM rapamycin for 6 weeks to develop rapamycin resistance. 10, 100,
250 and 500 μM myricetin was applied to rapamycin resistant HepG2 human hepatocellular cancer cells (HepG2-RR)
for 24 and 48 hours. Changes in ATF2, SMAD3, SMAD4 and Col1A1 expressions of HepG2-RR cells after myricetin
application were evaluated by Western blot and qPCR analysis. In addition, the effect of myricetin treatment on the
migration/invasion of HepG2-RR cells was specified using the BD 24-well Boyden chamber. The IC50 values of
rapamycin and myricetin on HepG2 cells for 48 hours incubation was calculated as 89,03±6,14 nM and 126,25±7,32 μM,
respectively. On the other hand, we found that HepG2-RR cells treated with myricetin decreased cell proliferation,
invasion, and migration by reducing the expression of ATF2, SMAD3, SMAD4, and Col1A1. As a result, we were shown
that myricetin administration inhibited cell growth and cell migration by suppressing ATF2 in hepatocellular carcinoma
cells that gained drug resistance.
Keywords :
Myricetin; Rapamycin; Liver Cancer; Metastasis